Cardiopulmonary bypass (CPB) is a nonphysiologic state that has many detrimental effects on a patient's hemostatic integrity. Exposure to the extracorporeal circuit and subsequent activation of the coagulation and fibrinolytic systems are factors that contribute to morbidity and mortality in cardiac surgical patients. These effects can be prevented in part or appropriately treated if practitioners understand the basic mecha nisms. This article reviews the effects of CPB on platelet function, the relationship of platelet function to post operative bleeding, the monitors available to measure platelet function, and the impact of antiplatelet therapy on bleeding in cardiac surgery.
Get full access to this article
View all access options for this article.
References
1.
Kevy SV, Glickman TM, Bernhard WF, et al: The pathogenesis and control of the hemorrhagic defect in open-heart surgery. Surg Gynecol Obstet123:313-318, 1966
2.
Signori EE, Penner JA, Kahn DR: Coagulation defects and bleeding in open heart surgery. Ann Thorac Surg8:521-529, 1969
3.
Porter JM, Silver D.: Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg56:869-878, 1968
4.
Bick RL: Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits. Semin Thromb Hem11:249-280, 1985
5.
Michelson AD , MacGregor H., Barnard MR, et al: Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost71:633-640, 1994
6.
Valeri CR, Khabbaz K., Khuri SF, et al: Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg104: 108-116, 1992
7.
Boldt J., Knothe C., Zickmann B., et al: Platelet function in cardiac surgery: influence of temperature and aprotinin. Ann Thorac Surg55:562-568, 1993
8.
Upchurch GR, Valeri CR, Khuri SF, et al: Effect of heparin on fibrinolytic activity and platelet function in vivo. Am J Physiol271:H528-H534, 1996
9.
Lindblad B., Wakefield TW, Whitehouse WM Jr, et al: The effect of protamine sulfate on platelet function. Scand J Thorac Cardiovasc Surg22:55-59, 1998
10.
Ammar, T., Fisher C.: The effects of heparinase I and protamine on platelet reactivity. Anesthesiology86:1382-1386, 1997
11.
Schafer AI, Adelman B.: Plasmin inhibition of platelet function and of arachidonic acid metabolism . J Clin Invest75:456-461, 1985
12.
Lu BH, Soria C., Cramer EM, et al: Temperature dependence of plasmin-induced activation or inhibition of human platelets. Blood77:996-1005, 1991
13.
Rinder CS, Matthew JP, Rinder HM, et al: Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology75:563-570, 1993
14.
Ferraris VA , Ferraris SP, Singh A., et al.: The platelet thrombin receptor and postoperative bleeding. Ann Thorac Surg65:352-358, 1998
15.
Shigeta O., Kojima H., Jikuya T., et al: Aprotinin inhibits plasmin induced platelet activation during cardiopulmonary bypass. Circulation96:569-574, 1997
16.
Stover EP, Siegel LC, Hood PA, et al: Platelet-rich plasma sequestration, with therapeutic platelet yields, reduces allogeneic transfusion in complex cardiac surgery. Anesth Analg90:509-516, 2000
17.
Lavee J., Martinowitz U., Mohr R., et al: The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations. A scanning electron microscope study of platelet aggregation on extracellular matrix. J Thorac Cardiovasc Surg97:204-212, 1989
18.
Shinfeld A. , Zippel D., Lavee J., et al: Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate. Ann Thorac Surg59:872-876, 1995
19.
Ereth MH, Nuttall GA, Klindworth JT, et al: Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass?Anesth Analg85:259-264, 1997
20.
Dong, Y., Nuttall GA, Bums T., et al: Comparative evaluation of,platelet function assays during cardiopulmonary bypass. Anesth Analg92:SCA78, 2001 (abstr)
21.
Despotis GJ , Levine V., Filos KS, et al: Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology85:1311-1323, 1996
22.
Shore-Lesserson L., Saleem R., Stone M., et al: Evaluation of the Ultegra®, point-of-care platelet function instrument during cardiac surgery. Anesthesiology93:A313, 2000 (abstr)
23.
Azar RR, McKay RG, Thompson PD, et al: Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes. J Am Coll Cardiol32:1996-2002, 1998
24.
Bhatt DL, Marso SP, Lincoff AM, et al: Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol35:922-928, 2000
25.
Savi P., Artcanuthurry V., Bornia J., et al: Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets. Br J Haematol97:185-191, 1997
26.
Herbert JM, Dol F., Bernat A., et al: The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost80:512-518, 1998
27.
Khuri SF, Valeri CR, Loscalzo J., et al: Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg60:1008-1014, 1995
28.
Kestin AS, Valeri CR, Khuri SF, et al: The platelet function defect of cardiopulmonary bypass. Blood82:107-117, 1993
Adelman B., Michelson AD, Loscalzo J., et al: Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions. Blood65:32-40, 1985
31.
Michelson AD , Barnard MR: Plasmin-induced redistribution of platelet glycoprotein Ib. Blood76:2005-2010, 1990
32.
Michelson, AD, Macgregor H., Barnard MR, et al: Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost71:633-640, 1994
33.
John LC, Rees GM, Kovacs IB: Reduction of heparin binding to and inhibition of platelets by aprotinin. Ann Thorac Surg55:1175-1179, 1993
34.
John LC, Rees GM, Kovacs IB: Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage. KThorac Cardiovasc Surg105:816-822, 1993
35.
Kang Y.: Thromboelastography in liver transplantation. Semin Thromb Hemost21:34-44, 1995
36.
Kang Y., Borland LM, Picone J., et al: Intraoperative coagulation changes in children undergoing liver transplantation. Anesthesiology71:44-47, 1989
37.
Miller BE, Mochizuki T., Levy JH, et al: Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg85:1196-1202, 1997
38.
Shore-Lesserson L., Manspeizer HE, et al: Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg88:312-319, 1999
39.
Spiess BD, Gillies BS, Chandler W., et al: Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth9:168-173, 1995
Hett DA, Walker D., Pilkington SN, et al: Sonoclot analysis. Br J Anaesth75:771-776, 1995
42.
Chapin JW, Becker GL, Hurlbert BJ, et al: Comparison of thromboelastograph and Sonoclot coagulation analyzer for assessing coagulation status during orthotopic liver transplantation. Transplant Proc21:35-39, 1989
43.
Peck SD: Evaluation of the in vitro detection of the hypercoagulable state using the thrombin generation test and plasma clot impedance test. Thromb Haemost42:764-777, 1979
44.
Greilich PE , Alving BM, Longnecker D., et al: Near-site monitoring of the antiplatelet drug abciximab using the Hemodyne analyzer and modified thrombelastograph . J Cardiothorac Vasc Anesth13:58-64, 1999
45.
Reid TJ, Snider R., Hartman K., et al: A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets. Vox Sang75: 270-277, 1998
46.
Carr MEJr: Measurement of platelet force: the Hemodyne hemostasis analyzer. Clin Lab Manage Rev9:312-314, 1995
47.
Bode AP, Lust RM: Masking of heparin activity in the activated coagulation time (ACT) by platelet procoagulant activity. Thromb Res73:285-300, 1994
48.
Despotis GJ , Levine V., Saleem R., et al: Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: A randomised controlled trial. Lancet354:106-110, 1999
49.
Smith JW, Steinhubl SR, Lincoff AM, et al: Rapid platelet-function assay: An automated and quantitative cartridge-based method. Circulation99:620-625, 1999
50.
Coller BS, Lang D., Scudder LE: Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade. Circulation95:860-867, 1997
51.
Coller BS, Folts JD, Scudder LE, et al: Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model. Blood68:783-786, 1986
52.
Bock M., De Haan J., Beck KH, et al: Standardization of the PFA-100(R) platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking, and oral contraceptives . Br J Haematol106:898-904, 1999
53.
Kundu SK, Heilmann EJ, Sio R., et al: Description of an in vitro platelet function analyzer—PFA—100 . Semin Thromb Hemost21:106-112, 1995
54.
Mammen EF, Comp PC, Gosselin R., et al: PFA-100 system: A new method for assessment of platelet dysfunction . Semin Thromb Hemost24:195-202, 1998
55.
Wahba A., Sander S., Birnbaum DE: Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery?Thorac Cardiovasc Surg46:228-231, 1998
56.
Stover EP, Siegal LC, Parks R., et al: Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24- institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology88:327-333, 1998
57.
Tuman KJ, McCarthy RJ, Djuric M., et al: Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay. J Cardiothorac Vasc Anesth8:144-149,1994
58.
Despotis GJ , Grishaber JE, Goodnough LT: The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion34: 290-296, 1994
59.
Despotis GJ , Santoro SA, Spitznagel E., et al: Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg107:271-279, 1994
60.
Despotis GJ , Skubas NJ, Goodnough LT: Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Semin Thorac Cardiovasc Surg: 11:84-104, 1999
61.
Shore-Lesserson L., Manspeizer HE, DePerio M., et al: Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg88:312-319, 1999
62.
Nuttall GA, Oliver WC, Santrach PJ, et al: Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology94:773-781, 2001
